Dr Reddys Laboratories Debt-to-Equity Ratio Growth & History (RDY)
Dr Reddys Laboratories's debt-to-equity ratio was 0.14 for fiscal 2025.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-03-31 | 0.14 | 0.07 | +105.83% |
| 2024 | 2024-03-31 | 0.07 | 0.03 | +77.20% |
| 2023 | 2023-03-31 | 0.04 | −0.13 | −78.12% |
| 2022 | 2022-03-31 | 0.17 | 0.00 | +1.49% |
| 2021 | 2021-03-31 | 0.17 | 0.06 | +48.65% |
| 2020 | 2020-03-31 | 0.11 | −0.13 | −53.01% |
| 2019 | 2019-03-31 | 0.24 | −0.16 | −39.13% |
| 2018 | 2018-03-31 | 0.40 | — | — |
Dr Reddys Laboratories quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-03-31 | 0.14 | 0.07 | +105.83% |
| Q4 2024 | 2024-03-31 | 0.07 | 0.03 | +77.20% |
| Q4 2023 | 2023-03-31 | 0.04 | −0.13 | −78.12% |
| Q4 2022 | 2022-03-31 | 0.17 | 0.00 | +1.49% |
| Q4 2021 | 2021-03-31 | 0.17 | 0.06 | +48.65% |
| Q4 2020 | 2020-03-31 | 0.11 | −0.13 | −53.01% |
| Q4 2019 | 2019-03-31 | 0.24 | −0.16 | −39.13% |
| Q4 2018 | 2018-03-31 | 0.40 | — | — |
Dr Reddys Laboratories debt-to-equity ratio trends
Over the last five fiscal years, Dr Reddys Laboratories's debt-to-equity ratio increased from 0.11 to 0.14, a change of 0.02. The latest reported quarter, Q4 2025, shows 0.14.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗